MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EDWARDS PERICARDIAL PATCH

Model Number 4700

Device Problem Adverse Event Without Identified Device or Use Problem (2993)

Patient Problems Endocarditis (1834); Fungal Infection (2419)

Event Date 05/29/2022

Event Type  Injury  

Manufacturer Narrative

Additional manufacturer narrative: the device was not returned to edwards for evaluation.Attempts to retrieve additional information is in process.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.

Event Description

Edwards learned through voluntary medwatch reporting of an event involving a 4700 bovine pericardial patch event reporting the following: patient had lv to aorta baffle with rv to pa conduits, pulmonary venous to r atrium baffle with augmentation of svc and ivc 2021 and l av valve and aortic valve replacement 2022.When a berlin vad was placed 2022, a large mass was noted infiltrating into vessel wall that was identified as aspergillus flavus.Concern for product contamination.

Event Description

Edwards received voluntary medwatch form involving a 4700 bovine pericardial patch event with a concern of product contamination after identifying aspergillus flavus vegetation in a non-edwards rv to pa conduit.The infection was discovered approximately 17 days post-implant.Per medical records, this is a 13 years old patient with history of heterotaxy and complex congenital cardiac anomaly who underwent multiple cardiac procedures since birth.Recently, the patient underwent cardiac catheterization which was complicated by aortic root and aortic valve injury requiring an emergent sternotomy to replace left avv and aortic valve with non-edwards valves along with patching the aortic sinus with an edwards bovine pericardial patch.The patient heart function continued to deteriorate and required vad placement on pod 16.Pre-operative tee showed a large mass above the avv in the non-edwards rv to pa conduit implanted in (b)(6) 2021.The non-edwards rv to pa conduit was explanted and replaced with another non-edwards conduit.Microbiology report confirmed fungal vegetation on the explanted conduit with infiltration into the vascular wall.

Manufacturer Narrative

H10.Additional manufacturer narrative: added information to a2, b5, h6.The investigation is still in progress; therefore, a conclusion has yet to be established.A supplemental report will be submitted accordingly upon investigation completion.

Manufacturer Narrative

Complaint is confirmed by medical records.There is no evidence to suggest an edwards manufacturing defect.Product is unable to be evaluated, however, medical records were provided.Per received medical records, a potential source of infection was not identified and there was no indication of infection of the 4700 bovine pericardial patch.A lot history review was performed and confirmed that no other complaints have been received for this sterilization lot for endocarditis from any source, including aspergillus flavus.A dhr review was performed and identified that the subject 4700 pericardial patch was subjected to the bioburden reduction process measures and results conformed to acceptance criteria.Edwards manufacturing mitigations include a bioburden reduction process and terminal sterilization process that is highly effective and validated to provide high sterility assurance.The terminal sterilization processing eliminates all microorganisms.Prosthetic device endocarditis occurring within 60 days of implantation generally reflects contamination arising in the perioperative period.There are many opportunities for organisms to seed a prosthesis perioperatively.In early cases of prosthetic device endocarditis, infections are almost universally related to contamination at the time of surgery.Microorganisms including the fungi identified from the endocarditis incident are rapidly inactivated and could not survive in edwards multi-stage processing or terminal liquid sterilization process.Edwards lifesciences provides sterile tissue bioprostheses to customers with a carefully designed robust sterilization process for which the efficacy has been demonstrated consistently and which provides a significant safety factor.Based on the information available and the results of our investigation, the source of infection is unable to be identified; however, it can be concluded that the 4700 bovine pericardial patch, as supplied by edwards lifesciences, would not be the source of the characterized aspergillus flavus from the infection.An edwards defect has not been confirmed.

Event Description

Per online obituary patient expired on post-operative day 84.

• Brand Name: EDWARDS PERICARDIAL PATCH
• Type of Device: PERICARDIAL PATCH
• Manufacturer (Section D): EDWARDS LIFESCIENCES; one edwards way; irvine CA 92614
• Manufacturer (Section G): EDWARDS LIFESCIENCES; one edwards way; irvine CA 92614
• Manufacturer Contact: reginald santos ; 1 edwards way; irvine, CA 92614 ; 9492502731
• MDR Report Key: 15026428
• MDR Text Key: 295954321
• Report Number: 2015691-2022-06791
• Device Sequence Number: 1
• Product Code: DXZ
• UDI-Device Identifier: 00690103144178
• UDI-Public: (01)00690103144178(17)240825
• Combination Product (y/n): N
• Reporter Country Code: US
• PMA/PMN Number: K082139
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: Other,Health Professional
• Reporter Occupation: Physician
• Type of Report: Initial,Followup,Followup
• Report Date: 10/04/2022

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: No
• Device Model Number: 4700
• Device Lot Number: 63938719
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: Yes
• Was the Report Sent to FDA?: No
• Initial Date Manufacturer Received: 06/22/2022
• Initial Date FDA Received: 07/15/2022
• Supplement Dates Manufacturer Received: 08/29/2022; 09/28/2022
• Supplement Dates FDA Received: 09/29/2022; 10/04/2022
• Was Device Evaluated by Manufacturer?: Device Not Returned to Manufacturer
• Date Device Manufactured: 08/25/2021
• Is the Device Single Use?: Yes
• Is This a Reprocessed and Reused Single-Use Device?: No
• Type of Device Usage: Initial
• Patient Sequence Number: 1
• Patient Outcome(s): Required Intervention; Life Threatening; Hospitalization
• Patient Age: 13 YR
• Patient Sex: Male